Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Received: 29 July 2020
Accepted: 2 July 2021
First Online: 27 July 2021
: The study protocol, interview guide, informed consent form, and recruitment flyers were approved by the New England Independent Review Board, now part of WCG: WIRB Copernicus Group (IRB #120170305). All subjects completed and submitted a signed IRB-approved informed consent form prior to participation.
: Not applicable.
: MKW, CS, AF, DS, and KR are full-time employees of Optum and received research funding from Novartis Pharmaceuticals Corporation to conduct the study. MB and DD are full-time employees of the study sponsor, Novartis Pharmaceuticals Corporation.